Eight quinolones were examined for their bacterial mutagenicity in the Ames Salmonella TA102 assay and for their effects in other bacterial genotoxicity assays. In the quantitative Ames plate incorporation assay, all eight quinolones induced His' deletion reversion in SalmoneUla tester strain TA102, with maximum reversion observed at about two to eight times the MIC. The quinolones also induced the SOS response. At quinolone concentrations close to the MIC, SOS cell filamentation gene suUd was induced in suLA::lacZ fusion strain Escherichia coli PQ37. RecA-mediated cleavage of lambda repressor in lambda::lacZ fusion strain E. coli BR513 was measurable at about 10 times the MIC, though no induction occurred at 20 ,ug of nalidixic or oxolinic acid per ml. Genotoxicity of quinolones also was observed in the BaciMus subtilis DNA repair assay, in which the mutant strain M45 (recA) was more susceptible to quinolones than its parent strain, H17 (rec+). The results from these analyses indicate that quinolones induce SOS functions and are mutagenic in bacteria; these properties correspond to their antimicrobial activities.
We recently observed that exposure of bacteria to subinhibitory concentrations of ciprofloxacin promoted development of increased resistance to several structurally unrelated antimicrobial agents (9) . Multidrug resistance in some cases has been attributed to single mutations leading to decreased drug permeability (13, 14) . However, it cannot be discounted that the pleiotropic changes for some quinolone-resistant mutants arose via multiple mutations and could have resulted from the error-prone SOS response induced by quinolones (4, 26) . These results, in addition to other reported effects of quinolones (i.e., plasmid curability, promotion of reversions and of forward mutations, and positive results in selected genotoxicity assays) (3, 7, 18, 27, 34) , suggest the possible bacterial mutagenicity of quinolones. In this study, we examined the effects of quinolones in the Ames Salmonella assay and in other bacterial genotoxicity assays.
The Ames Salmonella assay (1, 20) is the most widely used of the bacterial mutagenesis assays and has been validated in several laboratories. This test measures back mutation in several specially constructed mutants of Salmonella typhimurium. In the original minimal battery, Ames et al. (1) recommended the use of five strains; each strain carried a his mutation and was defective in excision repair (uvrB) and in envelope permeability (rfa). Since then, a new minimal battery of four strains has been recommended (20) . The strains in the new battery carry his and rfa mutations and harbor mucAB-encoded plasmid pKM101. mucAB genes are analogs of SOS umuDC genes. Inductions of umuD and umuC genes are required for mutagenesis of Escherichia coli by certain agents. The phenotypes caused by the umuDC operon are highly dependent on its dosage and level of expression. Thus multicopies of pKM101 in the newly derived Ames strains enhance the strains' sensitivity for detection of mutagens. Moreover, in uvr+ bacteria, MucAB proteins may be more efficient than UmuDC in mediating * Corresponding author.
error-prone postreplication repair, resulting in increased survival (12) and mutability (24) after UV irradiation.
One of the newly recommended Ames Salmonella tester strains is TA102 (17) . It contains a hisG428 ochre mutation in which GC is substituted with AT. This is unlike the other Salmonella tester strains, which detect mutagens damaging GC base pairs. The hisG428 mutation is encoded on a multicopy pAQ1 plasmid; TA102 contains the hisAG8476 deletion on the chromosome. TA102 is excision-repair proficient (uvr+).
The positive result of quinolones in the Ames test was first reported for nalidixic acid and oxolinic acid (18) . This observation was expanded by Ysern et al. (36) , who observed that nalidixic acid, ofloxacin, enoxacin, and ciprofloxacin increased reversion of the hisG428 mutation in TA102 but not in other Ames Salmonella tester strains (TA98, TA100, TA1537, and TA1535). Finally, Gocke (10) confirmed the positive Ames test for ofloxacin, ciprofloxacin, fleroxacin, oxolinic acid, and enrofloxacin and further suggested that a functioning excision-repair system was required for mutagenesis of quinolones in salmonellae. The purpose of this study was to expand on these observations with additional known quinolones and S. typhimurium TA102 and to employ other bacterial genotoxicity assays in the evaluation of these agents. (20) , without metabolic activation (S9 mix). Spot tests for mutagenicity were performed with 0.05 mM L-histidine. For some experiments, the L-histidine concentration was increased to 0.2 mM. The positive control for the TA102 assay was NQNO, and the negative controls were amikacin and cefepime. Sensitivities of the His' revertants to the histidine analog N-(2-thiazolyl)-DL-alanine were determined by the radial streak plate method of Levin et al. (18) .
MATERIALS AND METHODS
In the SOS Chromotest, liquid suspension assays were used to detect P-galactosidase activity of the sulA::lacZ fusion strain PQ37 (25, 30) . Serial twofold dilutions, between 0.025 and 20 ,g/ml, of the quinolone and other compounds were tested. 3-Galactosidase activity was measured atA414 6 h after addition of the compound to PQ37 (19) . Absorbance values were plotted against the concentrations of compound tested. The concentrations tested giving peak absorbance and minimum induction above an A414 of 0.2 absorbance units were determined. The biochemical X prophage induction assay (BIA) was used to measure ,B-galactosidase activity in the lambda::lacZ fusion strain BR513 (5). ,B-Galactosidase activity was measured at A414 4 h after addition of the compound to BR513 (19) . The concentrations tested and the data analysis performed were similar to those done for the SOS Chromotest.
The susceptibilities of DNA repair-proficient B. subtilis H17 and its DNA repair-defective mutant M45 (rec assay) to compounds were determined by the well-agar diffusion method (16, 19) . Routinely, the concentration of the compounds tested was 20 ,ug/ml. The recA strain was considered to be preferentially susceptible to a compound if its mean inhibitory-zone diameter difference (difference between values for M45 and H17) was at least 3 mm larger than the zone diameter of strain H17.
Mitomycin was the positive control for the SOS Chromotest, BIA, and rec assay. Amikacin and/or chloramphenicol was a negative control for these assays. As with the quantitative Ames assay, quinolones such as ciprofloxacin were positive in the qualitative Ames spot test with strain TA102 (Fig. 1) . When the recommended 0.05 mM L-histidine was incorporated into the top agar, only a slight increase in His' revertants close to disks containing 0.02 or 0.04 ,ug of ciprofloxacin was observed. The ciprofloxacin MIC for TA102 was 0.03 ,ug/ml. Around disks containing higher concentrations of ciprofloxacin, only a zone of inhibition was observed, with no enhanced ring of growth above the background growth. L-Histidine supplementation of the selective agar is needed to allow for a period of viability during which initial DNA damage results in mutagenesis. Accordingly, the L-histidine concentration was increased fourfold (i.e., to 0.2 mM) to allow for a longer viable period during which ciprofloxacin could diffuse through the agar and affect bacterial cells. Indeed, at 0.2 mM L-histidine, a more visible ring of enhanced reversion a few millimeters from the 0.02-, 0.04-, and 0.08-,ug ciprofloxacin disks was observed (Fig. 1) .
RESULTS

Mutagenicity of quinolones in the Ames
Mutagenicity of quinolones in the SOS Chromotest. The abilities of quinolones to induce sulA (sfiA), a gene controlled by the general repressor of the SOS system, in the sulA::lacZ fusion strain PQ37 are summarized in Table 2 . Though all the quinolones induced sulA, they differed in their inducing potencies. Temafloxacin, tosufloxacin, ofloxacin, and ciprofloxacin were the strongest inducers of sul4, with maximum induction occurring at 0.05 to 0.2 ,ug of these agents per ml. Conversely, nalidixic and oxolinic acids were the poorest inducers, with peak sulA induction observed at 5 and 0.6 ,ug of the compounds per ml, respectively. The minimal sulA-inducing concentrations correlated closely (35) , mutations from streptomycin dependency (3), and mutations in the lactose and galactose operons (27) . Quinolones were also active in the B. subtilis rec assay, which detected DNA-damaging chemicals by their increased inhibitory activity against DNA repair-defective bacterial strain M45 compared with that against its DNA repairproficient parent H17. Positive rec assay results were observed for 20 j±g of oxolinic acid per ml and for much higher concentrations of nalidixic acid (80 ,ug/ml). Positive rec assay results for nalidixic acid have been reported for the B. subtilis H17/M45 system (16, 22) and for nalidixic and oxolinic acids with other DNA repair-defective strains (23, 24) . A positive B. subtilis H17/M45 assay has also been reported for quinolone DL-8280 (31).
Other short-term bacterial genotoxicity assays in which quinolones were positive were the E. coli SOS Chromotest and the BIA. Both tests measure induction of the SOS system resulting from DNA damage or inhibited DNA replication. The SOS gene sulA was induced by all the quinolones tested, with minimal induction occurring at concentrations near the MICs for strain PQ37. The quinolones also induced X prophage in the BIA. This induction occurs as the result of X repressor cleavage by activated RecA (5) . The range of quinolone concentrations at which this induction occurred was quite narrow, often within a two-to fourfold range in concentration. Moreover, while the quinolone concentration for SOS induction paralleled the compound's activity against E. coli BR513, maximum induction occurred at a concentration approximately 10-fold greater than the MIC. Although X prophage induction with nalidixic or oxolinic acid in the BIA was not observed for up to 20 ,ug of nalidixic acid per ml in this study, Elespuru and White (5) reported positive BIA results. Furthermore, nalidixic acid was reported as a prophage inducer in E. coli W2252 (32), and oxolinic acid and fleroxacin were reported as inducers in E. coli D22 (10) as determined by plaque-forming measurements. Positive induction of the SOS genes (suU, umuC, and recA) by quinolones has been reported by several other groups (22) (23) (24) (25) (26) (27) (28) (29) 36) .
These data on the abilities of quinolones to affect mutational rates, to induce SOS genes, to preferentially inhibit strains with defective DNA-repair systems, and to induce X prophage are evidence of their bacterial genotoxicity. Many mutagenic genotoxins are also SOS inducers, and errorprone SOS repair plays an important role in the mutagenesis induced by most chemical mutagens (25, 30) ; the SOS induction by quinolones strongly concurs with their abilities to induce mutations. However, the DNA lesions produced in the presence of quinolones (33) differ from those generated from chemicals that can directly damage or react with DNA. This difference could account for the activities of quinolones in the Ames Salmonella TA102 test and other genotoxicity assays.
A concern about quinolones has been their genotoxic effects on eukaryotic cells. Quinolones have been reported to affect eukaryotic cells in vitro by inducing unscheduled DNA synthesis, DNA strand breakage, inhibition of cell growth, and inhibition of immunoglobulin secretion in human lymphocytes (2, 6, 13, 23) . The in vivo effects of quinolones on eukaryotic cells are not as well documented and are usually negative (21, 23) . However, abnormal bone marrow cells were observed for mice given five daily parenteral doses of the quinolone CP-67,015 at 500 mg/kg of body weight per day (11) .
The possible mutagenic effect observed for quinolones in vitro has not posed a concern for their use in vivo. Quinolones currently in use are considered antibacterial agents, many being 100-fold more active against prokaryotic topoisomerase II than against its eukaryotic counterpart (15). Nevertheless, peak levels of quinolones in the urinary tract of humans range from 100 to 650 ,ug/ml (6, 11) , and quinolones have been shown to concentrate intracellularly (8, 11) .
We have proposed that the recent emergence of broad antibacterial resistance observed in some ciprofloxacin-resistant clinical strains and in some variants derived in vitro could result via the quinolone-induced error-prone SOS response (9) . The mutagenicity of an antibacterial compound could have profound effects on its useful lifetime as a therapeutic agent and on the prolonged usefulness of other antimicrobial agents. Mutagenicity of quinolones in the BIA. The abilities of quinolones to induce bacteriophage are summarized in Table 3 . Bacteriophage X induction is the result of RecA activation and proteolytic cleavage of the X repressor. As with the SOS Chromotest, quinolones differed in their abilities and their potencies to induce X prophage. Again, tosufloxacin, temafloxacin, ofloxacin, and ciprofloxacin were the most potent inducers of X prophage, with induction occurring at 0.03 to 0.05 ,ug/ml. No prophage induction was observed with nalidixic and oxolinic acids at the drug concentrations tested. The range of concentrations at which quinolones induced A prophage was very narrow. Thus the peak and minimal prophage-inducing concentrations for the quinolones were generally the same. The minimum concen- trations of quinolones that induced A prophage were generally 10-fold higher than their MICs for E. coli BR513. As expected, mitomycin but not amikacin or chloramphenicol induced X prophage.
Repairable DNA damage by quinolones in the B. subtilis rec assay. Most of the quinolones tested showed modest preferential toxicity to B. subtilis M45 (recA) over strain H17 (recA+) when tested at 20 ,ug/ml (Table 4) . Nalidixic acid showed differential activity at 80 ,ug/ml but no difference in activity against M45 and H17 at 20 or 40 ,ug/ml. As anticipated, mitomycin showed marked activity in the rec assay, whereas amikacin was not active.
DISCUSSION
The results of several bacterial genotoxicity assays clearly show that quinolones are DNA reactive and mutagenic to bacteria. Quinolones differed in their relative genotoxic abilities, with the more potent antibacterial derivatives being genotoxic at lower quinolone concentrations.
All the quinolones tested thus far induced His' revertants in Salmonella strain TA102. They differed, however, in their inducing potencies. The concentration at which the maxi- 
